MANHATTAN MANDARIN LTD

Company number 14071819 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

MANHATTAN MANDARIN LTD - Analysis Report

Company Number: 14071819

Analysis Date: 2025-07-29 13:54 UTC

  1. Risk Rating: HIGH
    The company exhibits significant solvency concerns, reflected in persistent negative net current assets and shareholders' deficit over consecutive years. The current liabilities substantially exceed current assets, indicating risk in meeting short-term obligations without additional funding.

  2. Key Concerns:

    • Negative Net Current Assets and Shareholders' Deficit: The company’s net current liabilities increased from £16,511 in 2023 to £31,134 in 2024, with shareholders' funds similarly negative, highlighting ongoing financial strain.
    • Reliance on Director/Shareholder Loans: The accounts note a £49,500 amount owed to the director, indicating dependence on related party funding rather than operational cash flow. This reliance may raise concerns about sustainability if such support ceases.
    • Limited Operational Scale and Revenue Information: The company is small with only one employee and no disclosed turnover or profit figures, limiting visibility on operational performance and cash generation capacity.
  3. Positive Indicators:

    • Compliance with Filing Requirements: The company is up to date with both accounts and confirmation statement filings, suggesting good regulatory compliance and governance in this regard.
    • Going Concern Statement Supported by Shareholder Support: The director’s report states that the company is a going concern based on shareholder financial support commitments, which mitigates immediate solvency risk.
    • No Auditor Qualification or Adverse Reports: The unaudited abridged accounts show no indication of audit concerns or qualifications, consistent with a small company exemption.
  4. Due Diligence Notes:

    • Investigate the nature and terms of the director’s loan (£49,500), including repayment arrangements and any risk of withdrawal.
    • Review operational cash flow and revenue streams to assess the company’s ability to reduce reliance on external funding.
    • Confirm whether additional equity or debt injections are planned to address the growing deficit and if there is a realistic plan to achieve profitability.
    • Consider obtaining management accounts or internal forecasts for a clearer picture of ongoing business viability.
    • Verify the absence of any director disqualifications or regulatory issues given the single director structure.

Perspective: Investment Risk Assessor · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.